SNCA and Parkinson disease: Parkinson's disease (PD) is one of the major neurodegenerative diseases, and is characterized by a selective degeneration of dopamine (DA) neurons and the formation of α-synuclein (α-syn)-containing Lewy bodies in the substantia nigra, with the subsequent loss of their terminals in the striatum [1], [2], [3].